Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

Bibliographic Details
Main Authors: Gold, R, Comi, G, Palace, J, Siever, A, Gottschalk, R, Bijarnia, M, von Rosenstiel, P, Tomic, D, Kappos, L
Format: Journal article
Language:English
Published: 2014

Similar Items